Log In
BCIQ
Print this Print this
 

VLP-IgE (PF-06444752)

  Manage Alerts
Collapse Summary General Information
Company Kuros Biosciences Ltd.
DescriptionAnti-IgE vaccine based on IgE peptides conjugated to the virus-like particle Qb
Molecular Target Immunoglobulin E (IgE)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today